Please assess the completion status of the following clinical trial:

Trial Title: Quantra® System With the QStat® Cartridge in Trauma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is \> 18 years; Children under the age of 18 are protected by adults under guardianship or by court order.~* Subject is a trauma patient experiencing traumatic injuries requiring a full trauma team response according to site's level 1of trauma team activation criteria.~* Subject, or subject's legally authorized representative (LAR), is willing to provide informed consent, either prospectively or by deferred consent.~Exclusion Criteria~* Subject is pregnant.~* Subject is currently enrolled in a distinct study that might confound the result of the proposed study.~* Subject is not covered by social security.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Quantra System with the QStat Cartridge (Type: EXPERIMENTAL): Decisions regarding transfusion of blood products will be made based on information derived from the Quantra System with the QStat Cartridge.
- Standard Laboratory Coagulation Testing (Type: ACTIVE_COMPARATOR): Decisions regarding transfusion of blood products will be made based on the site's standard of care which is information derived from standard laboratory coagulation tests.

Based on this trial design, predict the completion outcome and termination type (if applicable).